Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K R Harrap

Showing results (111-120 of 138) with videos related to

Pageof 14
Sort By:
Cancer Research|April 1, 1992
Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell lineL R Kelland, P Mistry, G Abel, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Preclinical toxicology and tissue platinum distribution of novel oral antitumour platinum complexes: ammine/amine platinum(IV) dicarboxylatesM J McKeage, S E Morgan, F E Boxall, et al.
Advances in Enzyme Regulation|January 1, 1989
Thymidylate synthase: a target for anticancer drug designK R Harrap, A L Jackman, D R Newell, et al.
Cancer Research|July 15, 1992
Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylatesL R Kelland, P Mistry, G Abel, et al.
British Journal of Cancer|December 1, 1996
The cytotoxic action of four ammine/amine platinum(IV) dicarboxylates: a flow cytometric studyM G Ormerod, R M Orr, C F O'Neill, et al.
Cancer Treatment Reports|March 1, 1981
Toxicity and immunosuppressive activity of binary combinations of 2'-deoxycoformycin and 2'-deoxyadenosineR M Paine, B J Weston, H M Clink, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
The clinical pharmacokinetics of the novel antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717)D L Alison, D R Newell, C Sessa, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1986
5-Ethyl-2'-deoxyuridine: an explanation for its lack of cytotoxic action in vivoA Jeney, S E Barrie, G A Taylor, et al.
Cancer Research|June 1, 1993
Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drugL R Kelland, G Abel, M J McKeage, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1995
ZD1694 (Tomudex): a new thymidylate synthase inhibitor with activity in colorectal cancerA L Jackman, D C Farrugia, W Gibson, et al.
Pageof 14

Showing results (111-120 of 138) with videos related to

Sort By:
Pageof 14
Cancer Research|April 1, 1992
Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell lineL R Kelland, P Mistry, G Abel, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Preclinical toxicology and tissue platinum distribution of novel oral antitumour platinum complexes: ammine/amine platinum(IV) dicarboxylatesM J McKeage, S E Morgan, F E Boxall, et al.
Advances in Enzyme Regulation|January 1, 1989
Thymidylate synthase: a target for anticancer drug designK R Harrap, A L Jackman, D R Newell, et al.
Cancer Research|July 15, 1992
Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylatesL R Kelland, P Mistry, G Abel, et al.
British Journal of Cancer|December 1, 1996
The cytotoxic action of four ammine/amine platinum(IV) dicarboxylates: a flow cytometric studyM G Ormerod, R M Orr, C F O'Neill, et al.
Cancer Treatment Reports|March 1, 1981
Toxicity and immunosuppressive activity of binary combinations of 2'-deoxycoformycin and 2'-deoxyadenosineR M Paine, B J Weston, H M Clink, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
The clinical pharmacokinetics of the novel antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717)D L Alison, D R Newell, C Sessa, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1986
5-Ethyl-2'-deoxyuridine: an explanation for its lack of cytotoxic action in vivoA Jeney, S E Barrie, G A Taylor, et al.
Cancer Research|June 1, 1993
Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drugL R Kelland, G Abel, M J McKeage, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1995
ZD1694 (Tomudex): a new thymidylate synthase inhibitor with activity in colorectal cancerA L Jackman, D C Farrugia, W Gibson, et al.
Pageof 14